IN RE U.S. BIOSCIENCE SECURITIES LITIGATION

No. 92-0678.

806 F.Supp. 1197 (1992)

In re U.S. BIOSCIENCE SECURITIES LITIGATION

United States District Court, E.D. Pennsylvania.

November 10, 1992.


Attorney(s) appearing for the Case

Sherrie R. Savett, Berger & Montague, P.C., Robert P. Frutkin, Savett, Frutkin, Podell & Ryan, P.C., Philadelphia, Pa., for plaintiff.

Richard Ben-Veniste, Greg A. Danilow, Weil, Gotshal & Manges, Washington, D.C., for defendant.

Richard L. Jacobson, Fulbright & Jaworski, Washington, D.C., for defendant, James E. Moore.


MEMORANDUM

DALZELL, District Judge.

Plaintiffs are individuals who purchased common stock or call options, or sold put options, of U.S. Bioscience from April 12, 1991 through January 31, 1992. They bring this action on their own and as representatives of a class against U.S. Bioscience, Inc. ("Bioscience") and several of its officers and directors, alleging violations of the federal securities laws and negligent misrepresentation.1

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases